收入
成本
利润
| Item | Category | Value | YoY |
|---|---|---|---|
| Net sales | revenue | 6.02B | 2.63% |
| Gross profit | profit | 3.81B | 1.76% |
| Reclassification to: cost of sales | cost | 2.21B | 4.15% |
| Other income | revenue | 62.00M | -3.12% |
| Segment operating income | profit | 936.00M | 11.83% |
| Total operating expenses | cost | 2.87B | -1.14% |
| Aggregate | revenue | 998.00M | 10.77% |
| Selling, general and administrative expenses | cost | 2.28B | -0.83% |
| Research, development and engineering expenses | cost | 413.00M | 1.98% |
| Amortization of intangible assets | cost | 180.00M | 7.78% |
| Earnings before income taxes | profit | 850.00M | 11.26% |
| Reclassification to: interest expense | cost | 148.00M | 8.03% |
| Net earnings | profit | 745.00M | 13.91% |
| Income taxes | cost | 105.00M | -4.55% |
| Segment | Value | YoY |
|---|---|---|
| MedSurg and Neurotechnology | 3.21B | 4.94% |
| Orthopaedics and Spine | 2.81B | 0.11% |
| Segment | Value | YoY |
|---|---|---|
| UNITED STATES | 4.48B | 0.81% |
| Non-US | 1.54B | 8.27% |
| Segment | Value | YoY |
|---|---|---|
| Trauma and Extremities | 1.03B | 9.52% |
| Instruments | 920.00M | 9.79% |
| Medical | 902.00M | -4.55% |
| Endoscopy | 868.00M | 0.12% |
| Knees | 670.00M | 4.85% |
| Ortho Tech | 646.00M | 4.70% |
| Neurovascular | 517.00M | 27.34% |
| Hips | 460.00M | 3.84% |
| Spinal Implants | 2.00M | -98.80% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Machinery and equipment | assets | 5.83B | |
| Finished goods | assets | 3.51B | |
| Land, buildings and improvements | assets | 1.79B | |
| Materials and supplies | assets | 1.47B | |
| Work in process | assets | 435.00M | |
| Total property, plant and equipment | assets | 7.63B | |
| Total inventories | assets | 5.42B | |
| Accounts receivable, less allowance of $225 ($216 in 2025) | assets | 3.57B | |
| Cash and cash equivalent | assets | 2.88B | |
| Prepaid expenses and other current assets | assets | 1.38B | |
| Available-for-sale securities, current | assets | 87.00M | |
| Total current assets | assets | 13.34B | |
| Property, plant and equipment, net | assets | 3.89B | |
| Less allowance for depreciation | assets | 3.74B | |
| Goodwill | assets | 19.19B | |
| Other intangibles, net | assets | 5.52B | |
| Other assets, noncurrent | assets | 3.17B | |
| Noncurrent deferred income tax assets | assets | 1.19B | |
| Assets | assets | 46.29B | |
| Total liabilities | liabilities | 23.31B | |
| Accumulated other comprehensive income (loss), net of tax | liabilities | 583.00M | |
| Total shareholders' equity | liabilities | 22.98B | |
| Long-term debt, excluding current maturities | liabilities | 14.22B | |
| Total current liabilities | liabilities | 6.32B | |
| Other noncurrent liabilities | liabilities | 2.37B | |
| Income taxes | liabilities | 403.00M | |
| Aggregate | liabilities | 23.56B | |
| Other liabilities, current | liabilities | 2.53B | |
| Accounts payable, trade, current | liabilities | 1.59B | |
| Accrued compensation | liabilities | 885.00M | |
| Current maturities of debt | liabilities | 499.00M | |
| Accrued income taxes, current | liabilities | 476.00M | |
| Dividends payable | liabilities | 337.00M | |
| Retained earnings (accumulated deficit) | liabilities | 20.88B | |
| Additional paid in capital, common stock | liabilities | 2.65B | |
| Common stock, $0.10 par value | liabilities | 38.00M |
| Item | Value |
|---|---|
| Net earnings | 745.00M |
| Increase (decrease) in accounts receivable | 444.00M |
| Amortization of intangible assets | 180.00M |
| Depreciation | 120.00M |
| Share-based compensation | 87.00M |
| Income taxes | 42.00M |
| Increase (decrease) in other operating assets and liabilities, net | -25.00M |
| Deferred income tax (benefit) expense | -33.00M |
| Increase (decrease) in inventories | -127.00M |
| Accounts payable | -198.00M |
| Accrued expenses and other liabilities | -654.00M |
| Item | Value |
|---|---|
| Proceeds from sales of marketable securities | 7.00M |
| Payment for (proceeds from) other investing activity | 1.00M |
| Payments to acquire marketable securities | -5.00M |
| Acquisitions, net of cash acquired | -22.00M |
| Payments to acquire property, plant, and equipment | -166.00M |
| Item | Value |
|---|---|
| Other financing, net | -34.00M |
| Payment, tax withholding, share-based payment arrangement | -139.00M |
| Payments of dividends | -337.00M |
| Payments of long-term debt | -1.00B |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 4.01B |
| Cash and cash equivalents, end of period | 2.88B |
快速穿透 10-K/10-Q 复杂数据。通过利润表及资产负债表桑基图，与现金流量表瀑布图，一站式洞悉企业财务流向。
在左侧搜索公司并选择一份报告。
申请股票支持